Jul 13, 2026 · 5 min
MGM rises on Diller takeover bid while SK Hynix tumbles on AI skepticism
MGM and Diller; SK Hynix Lower; Agenus Jump
This episode highlights how shifting investor confidence is cooling semiconductor stocks while driving major moves in entertainment and biotechnology.
- 1MGM Resorts shares jumped following news that media executive Barry Diller is exploring a takeover proposal.
- 2SK Hynix led a decline in memory chip stocks as investors question the long-term returns on AI infrastructure spending.
- 3Biotech firm Agenus saw its stock price surge after securing a major private placement deal.
Don't miss
The discussion on SK Hynix experiencing a record drop in Asia due to sudden investor skepticism over global AI spending.
The brief
MGM Resorts shares are climbing on news that media mogul Barry Diller is evaluating a takeover proposal, signalling a potential major shakeup in the entertainment and hospitality sector.
Meanwhile, semiconductor giant SK Hynix suffered a record drop in Asia as investors begin to question the long-term sustainability of massive corporate spending on artificial intelligence.
In the biotech space, Agenus shares surged following a major private placement deal, while Disney prepares its theatrical release strategy for the highly anticipated Moana 2.
What was said on this episode
6 statements · 1 positive · 4 negative · 1 neutral
Barry Diller’s offer values MGM at approximately $12.4 billion.
“That values MGM at about $12.4 billion.”
Listen at 1:21
SK Hynix fell 15% in Asia, its largest recorded decline.
“South Korean memory chip maker falling 15% in Asia. That is a record for this company.”
Listen at 1:37
A South Korean brokerage forecasts SK Hynix second-quarter earnings below expectations.
“a brokerage firm in South Korea is forecasting second quarter earnings for SK Hynix below expectations”
Listen at 1:53
Slower SK Hynix memory-chip shipments are weighing on the broader sector.
“That's bringing the whole memory chip sector lower today.”
Listen at 2:05
Agenus will use financing proceeds for colon-cancer treatment research and extend cash through 2031.
“Proceeds going to go toward finding a treatment for colon cancer and extend its cash Runway through the end of 2031.”
Listen at 2:40
Disney’s live-action Moana grossed $43 million domestically against a $250 million budget.
“Disney live action version of Oana flopping at the box Office grossed just $43 million in the US it had a budget of 250 million.”
Listen at 2:50
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Barry Diller
Walt DisneyListen to the full episode and explore every guest, topic, and moment on PodLume.